Supplementary file ACS. by Prajwal Paudel (7359209)

Subjects:

Multivariate analysis of the outcomes among the newborns who mothers receive or did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

Bivariate analysis of morbidities among newborns whose mothers received or did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

Multivariate analysis of the morbidities among the newborns who mothers receive or did not receive ACS. by Prajwal Paudel (7359209)

Subjects:

<i>T</i>. <i>spiralis</i> IIL ESP reduced TJ protein expression and destroyed the integrity of Caco-2 monolayer. by Qi Qi Lu (17721401)

Subjects:

Induction of RoxS leads to decreased <i>ppnKB</i> mRNA levels. Northern blot showing decreased <i>ppnKB</i> mRNA levels upon RoxS induction. by Sylvain Durand (67030)

Progressive decrease in expression of Kcnj10, Kcnq1, Gjb2 and Gjb6 in <i>Spns2^tm1a/tm1a</i> mice. by Jing Chen (4762)

Klf5 down-regulation leads to human VSMC senescence. by Dong Ma (584680)

Purified serum IgG from SPMS patients decreased the amount of claudin-5 protein, and IgG from all clinical subtypes of MS patients increased the amount of VCAM-1 protein in TY09 ce... by Fumitaka Shimizu (545145)

“…(G) The amount of VCAM-1 protein in the TY09 cells was significantly increased after exposure to the purified IgG fraction from patinets with all clinical subtypes of MS, whereas it was not changed by the IgG from healthy controls, as determined by a Western blot analysis. (H) The TEER value of the TY09 cells was significantly decreased after exposure to the purified IgG fraction from SPMS patients, although it was not changed by incubation with the purified serum IgG fractions from RRMS-R or RRMS-S patients, or from healthy controls (mean ± SEM, SPMS n = 6, RRMS-R n = 4, RRMS-S n = 6, Normal n = 5). …”

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism. by Daniel P. Bradley (10306893)

1466 does not change total yield of capsids during biochemical assembly reactions. by Daniel P. Bradley (10306893)

1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

Top 50 results of a commercial kinase screen using [γ³³]-ATP and human obscurin SH3-DH as substrates. by Daniel Koch (388049)

“…While MST2 addition resulted in strong and saturable phosphorylation, TBK1 led to much lower phosphorylation levels and CaMK4 addition led to an intermediate phosphorylation level exhibiting a biphasic behaviour with phosphorylation levels decreasing at higher substrate concentrations. …”

αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells. by Daniel P. Bradley (10306893)

Compound structures and preferential inhibition of the HBV plus-polarity DNA strand. by Daniel P. Bradley (10306893)

Supramolecular DNA Photonic Hydrogels for On-Demand Control of Coloration with High Spatial and Temporal Resolution by Yixiao Dong (2174902)

“…We solve this problem by creating a DNA hydrogel system that shows a 50 000-fold decrease in modulus upon heating by ∼10 °C. …”